| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired EGFR L718V Mutation as the Mechanism for Osimertinib Resistance in a T790M-Negative Non-Small-Cell Lung Cancer Patient
|
Yang, Zhe
|
|
2019
|
14 |
4 |
p. 369-374
|
artikel
|
| 2 |
A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma
|
Nigim, Fares
|
|
2019
|
14 |
4 |
p. 479-489
|
artikel
|
| 3 |
Combination Treatment with an Antibody–Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer
|
Wan, Y. Louise
|
|
2019
|
14 |
4 |
p. 465-477
|
artikel
|
| 4 |
Correction to: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR‑Mutant Lung Adenocarcinoma
|
Li, Changhui
|
|
2019
|
14 |
4 |
p. 491
|
artikel
|
| 5 |
Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung Adenocarcinoma
|
Li, Changhui
|
|
|
14 |
4 |
p. 423-431
|
artikel
|
| 6 |
Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up
|
Chalmers, Anna W.
|
|
2019
|
14 |
4 |
p. 417-421
|
artikel
|
| 7 |
Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma
|
Ishihara, Hiroki
|
|
2019
|
14 |
4 |
p. 453-463
|
artikel
|
| 8 |
Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib
|
Kuo, Chih-Hsi Scott
|
|
2019
|
14 |
4 |
p. 433-440
|
artikel
|
| 9 |
Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane
|
Willemsen, Annelieke E. C. A. B.
|
|
2019
|
14 |
4 |
p. 441-451
|
artikel
|
| 10 |
Relative Efficacy of Systemic Treatments for Patients with Advanced Hepatocellular Carcinoma According to Viral Status: A Systematic Review and Network Meta-Analysis
|
Park, Jisun
|
|
2019
|
14 |
4 |
p. 395-403
|
artikel
|
| 11 |
Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data
|
Moran, Michael
|
|
2019
|
14 |
4 |
p. 405-416
|
artikel
|
| 12 |
The Role of Checkpoint Inhibitors in Glioblastoma
|
Desai, Kunal
|
|
2019
|
14 |
4 |
p. 375-394
|
artikel
|
Tijdschrift beschrijving